介绍

本页面提供了有关 Douglas B Given 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Douglas B Given已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:ARWR / Arrowhead Pharmaceuticals, Inc. Director 124,167
如何解读这些图表

以下图表显示了在Douglas B Given进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

内幕交易历史

该表格显示了由 Douglas B Given 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2024-12-18 2024-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -547 124,167 -0.44 22.04 -12,056 2,736,641
2024-12-18 2024-12-16 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,000 124,714 -3.85 21.90 -109,500 2,731,237
2024-01-16 2024-01-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,100 129,711 -0.84 38.55 -42,405 5,000,359
2024-01-16 2024-01-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,811 130,811 -1.37 37.76 -68,383 4,939,423
2023-12-19 2023-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 14,987 132,622 12.74 25.41 380,820 3,369,925
2023-05-08 2023-05-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -6,500 117,635 -5.24 40.90 -265,850 4,811,272
2023-03-01 2023-02-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -875 13,000 -6.31 32.62 -28,542 424,060
2023-01-11 2023-01-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 7,867 124,135 6.77
2022-01-07 2022-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 6,400 116,268 5.83
2021-12-29 2021-12-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
P - Purchase 655 109,868 0.60 66.37 43,472 7,291,939
2021-12-29 2021-12-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -655 109,213 -0.60
2021-09-10 2021-09-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,000 109,868 -4.35 65.24 -326,200 7,167,788
2021-06-24 2021-06-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -4,500 114,868 -3.77 89.21 -401,445 10,247,374
2021-02-24 2021-02-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,125 13,875 -7.50 88.73 -99,821 1,231,129
2021-01-19 2021-01-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -3,000 12,500 -19.35 83.28 -249,840 1,041,000
2021-01-05 2021-01-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -4,000 119,368 -3.24 76.08 -304,320 9,081,517
2021-01-05 2021-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 9,500 123,368 8.34
2020-12-29 2020-12-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -35 113,868 -0.03
2020-12-29 2020-12-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -35 113,903 -0.03
2020-12-29 2020-12-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -200 113,938 -0.18
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -35 114,138 -0.03
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -35 114,138 -0.03
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -200 114,208 -0.17
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -200 114,208 -0.17
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -65 114,608 -0.06
2020-12-29 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -65 114,608 -0.06
2020-12-18 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -500 15,000 -3.23 79.59 -39,795 1,193,850
2020-12-18 2020-12-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -9,075 114,738 -7.33 79.30 -719,648 9,098,723
2020-12-18 2020-12-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift 15,500 15,500
2020-12-18 2020-12-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift 15,500 15,500
2020-12-18 2020-12-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -31,000 123,813 -20.02
2020-04-16 2020-04-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -1,112 154,813 -0.71
2020-04-16 2020-04-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -25,000 155,925 -13.82 36.89 -922,250 5,752,073
2020-01-03 2020-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 8,000 180,925 4.63
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -7,000 0 -100.00
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -10,000 7,000 -58.82
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -18,000 17,000 -51.43
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -30,000 35,000 -46.15
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -65,000 175,130 -27.07 19.25 -1,251,250 3,371,252
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,000 240,130 3.00 4.75 33,250 1,140,618
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 233,130 4.48 2.62 26,200 610,801
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 18,000 223,130 8.77 2.19 39,420 488,655
2019-02-26 2019-02-26 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30,000 205,130 17.13 5.19 155,700 1,064,625
2019-02-26 2019-02-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,000 175,130 -1.68 18.05 -54,150 3,161,096
2019-01-24 2019-01-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,000 178,130 -1.66 13.58 -40,740 2,419,005
2019-01-03 2019-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 36,000 181,130 24.81
2018-12-28 2018-12-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,000 145,130 -2.03 12.00 -36,000 1,741,560
2018-11-26 2018-11-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,000 148,130 -1.99 12.74 -38,220 1,887,176
2018-10-23 2018-10-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -3,870 151,130 -2.50
2018-04-25 2018-04-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25,000 155,000 -13.89 6.63 -165,750 1,027,650
2018-01-03 2018-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 30,000 180,000 20.00
2017-01-04 2017-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 80,000 150,000 114.29
2016-10-18 2016-10-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -12,000 70,000 -14.63 6.72 -80,640 470,400
2016-10-18 2016-01-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -8,000 82,000 -8.89
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 35,000 90,000 63.64
2015-03-06 2015-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 35,000 55,000 175.00
2014-09-30 2014-09-26 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option (right to buy)
M - Exercise -2,000 65,000 -2.99
2014-09-30 2014-09-26 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
S - Sale X -2,000 20,000 -9.09 15.24 -30,480 304,800
2014-09-30 2014-09-26 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
M - Exercise 2,000 22,000 10.00 2.19 4,380 48,180
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option (right to buy)
M - Exercise -5,000 67,000 -6.94
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
S - Sale -5,000 20,000 -20.00 13.90 -69,500 278,002
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
M - Exercise 5,000 25,000 25.00 2.01 10,050 50,250
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 20,000 20,000
2013-09-24 2013-09-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 7,000 72,000 10.77
2013-05-08 2013-05-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 5,000 65,000 8.33
2013-04-01 2013-03-21 4/A ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 20,000 60,000 50.00
2013-03-25 2013-03-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award -20,000 60,000 -25.00
2012-10-02 2012-09-28 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award -10,000 40,000 -20.00
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)